πŸ•΅οΈ Oncolytics Biotech Inc ($ONCY)

SEC insider & ownership activity, last 12 months Β· CIK 1129928 Β· every row links its SEC filing

Over the last 12 months insiders bought $363K with no open-market selling against it. Bernd R. Seizinger bought $187K in discretionary trades (Jan–Feb). One red-flag 8-K in the window: Delisting notice (3.01), Jul 20, 2026.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net +$104K Mar 2026: net +$15K Mar 2026: net +$15K Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

10 buyers, $363K (14 lots) Β· 0 sellers, $0 (0 lots)

InsiderBuysBoughtSellsSoldLast
Bernd R. Seizinger3$187K 0–Feb 12, 2026
Kelly Jared3$34K 0–Mar 12, 2026
Patricia S. Andrews1$30K 0–Feb 12, 2026
Aromando Andrew1$25K 0–Feb 11, 2026
Pisano Wayne1$25K 0–Feb 12, 2026
Brown Deborah Margaret1$21K 0–Feb 12, 2026
James T. Parsons1$10K 0–Mar 11, 2026
Look Kirk1$10K 0–Feb 12, 2026
Heineman Thomas Charles1$10K 0–Feb 12, 2026
Hagerman Allison1$8K 0–Feb 12, 2026

5%+ holders

HolderStakeClassScheduleEvent
Anson Funds Management LP 7.0% 13GNov 14, 2025 filing β†—
Anson Management GP LLC 7.0% 13GNov 14, 2025 filing β†—
Tony Moore 7.0% 13GNov 14, 2025 filing β†—
Anson Advisors Inc. 7.0% 13GNov 14, 2025 filing β†—
Amin Nathoo 7.0% 13GNov 14, 2025 filing β†—
Moez Kassam 7.0% 13GNov 14, 2025 filing β†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Delisting notice (3.01)Jul 20, 2026 filing β†—
Other events (8.01)Jul 20, 2026 filing β†—
Other events (8.01)Jul 13, 2026 filing β†—
Auditor change (4.01)Jul 6, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jul 6, 2026 filing β†—
Other events (8.01)Jun 16, 2026 filing β†—
Officer/director changes (5.02)Jun 2, 2026 filing β†—
Other events (8.01)Jun 2, 2026 filing β†—
Other events (8.01)Jun 1, 2026 filing β†—
Other events (8.01)May 22, 2026 filing β†—
Other events (8.01)May 4, 2026 filing β†—
Other events (8.01)Apr 27, 2026 filing β†—
Other events (8.01)Apr 6, 2026 filing β†—
Other events (8.01)Apr 6, 2026 filing β†—
Financial Statements and Exhibits (9.01)Apr 6, 2026 filing β†—
Material agreement (1.01)Mar 31, 2026 filing β†—
Material Modifications to Rights of Security Holders (3.03)Mar 31, 2026 filing β†—
Officer/director changes (5.02)Mar 31, 2026 filing β†—
Charter/bylaw changes (5.03)Mar 31, 2026 filing β†—
Other events (8.01)Mar 31, 2026 filing β†—
Financial Statements and Exhibits (9.01)Mar 31, 2026 filing β†—
Other events (8.01)Mar 19, 2026 filing β†—
Material Modifications to Rights of Security Holders (3.03)Mar 17, 2026 filing β†—
Charter/bylaw changes (5.03)Mar 17, 2026 filing β†—
Financial Statements and Exhibits (9.01)Mar 17, 2026 filing β†—
Other events (8.01)Mar 2, 2026 filing β†—
Other events (8.01)Feb 24, 2026 filing β†—
Other events (8.01)Feb 4, 2026 filing β†—
Shareholder vote (5.07)Jan 15, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jan 15, 2026 filing β†—